Skip to the answer

Ipratropium Uses, Dosage, Side Effects and Interactions

Brand names
Atrovent

Atrovent was the first ipratropium product the FDA approved, in December 1986. An FDA-approved generic with the same active ingredient is listed.

Atrovent HFA

Atrovent HFA came 17 years after Atrovent (November 2004) as an inhaler. An FDA-approved generic with the same active ingredient is listed.

Ipratropium is an anticholinergic medicine used to treat bronchospasm (airway tightening) in COPD and to relieve a runny nose caused by the common cold or seasonal allergic rhinitis.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About IpratropiumType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Ipratropium in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Ipratropium (Atrovent), an older anticholinergic on the U.S. market since about 1986 with FDA-approved generics listed, blocks the nerve signal acetylcholine, relaxing tight airways when inhaled for COPD and drying up mucus glands when sprayed for a runny nose from colds or hay fever. Little reaches the bloodstream, so it is well tolerated beyond dry mouth, a bitter taste or headache. If breathing suddenly tightens right after an inhaled dose (paradoxical bronchospasm, a rare reaction), stop it and call your doctor right away. Mention glaucoma or an enlarged prostate first, and keep sprays out of your eyes, since it can raise eye pressure and make urinating hard.

Key Takeaways From the HelloPharmacist Team

  • For COPD, use it every day on schedule, the inhaler four times a day or the nebulizer three to four times a day.
  • Keep a quick-relief inhaler such as albuterol for sudden breathing attacks, because inhaled ipratropium is daily maintenance, not a rescue medicine.
  • Expect the nasal spray to stop dripping, not stuffiness or sneezing; for a cold, the label covers only four days of use.
  • Avoid stacking it with other anticholinergic drugs, including some bladder medicines like oxybutynin, which multiply dry mouth and trouble urinating.

How we write and review this content: our editorial policy

Ipratropium by the Numbers

Strengths
4
across 3 forms
Makers and packagers
24
Earliest FDA record
1986
Rank by Medicaid prescriptions
#247 of 1,666 drugs
More prescriptions than 85% of the 1,666 drugs we measure
583,555 prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Ipratropium

What It’s Used For

Ipratropium is available in inhaled and nasal forms, each approved for specific conditions. Here is the full set of supported uses:

  • COPD maintenance (inhaled aerosol — Atrovent HFA): Atrovent HFA is approved as a bronchodilator for ongoing management of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
  • COPD maintenance (inhaled aerosol — Ipratropium Bromide Inhalation aerosol): Ipratropium Bromide Inhalation aerosol is approved for maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
  • COPD maintenance (nebulizer solution — Ipratropium Bromide): Ipratropium Bromide inhalation solution (nebulizer) is approved for maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema — used alone or with other bronchodilators, especially beta-adrenergic medicines.
  • Runny nose from the common cold (nasal spray — Ipratropium Bromide): Ipratropium Bromide nasal spray 0.06% is approved for symptomatic relief of rhinorrhea (runny nose) from the common cold in adults and children aged 5 and older; approved for up to 4 days.
  • Runny nose from seasonal allergic rhinitis (nasal spray — Ipratropium Bromide): Ipratropium Bromide nasal spray 0.06% is approved for symptomatic relief of rhinorrhea from seasonal allergic rhinitis in adults and children aged 5 and older; approved for up to 3 weeks.

How It Works

Ipratropium is an anticholinergic medicine, meaning it blocks the action of acetylcholine — a chemical your nervous system uses to signal muscles and glands. In the lungs, blocking this signal prevents the airways from tightening, which makes it easier to breathe. In the nose, it reduces activity in the mucus-producing glands lining the nasal passages, which cuts down on a runny nose. Because ipratropium is a quaternary amine — a chemical structure that doesn't cross easily into the bloodstream or the brain — most of its action stays local, at the site where it's applied, and whole-body (systemic) anticholinergic side effects are much less common than with older medicines in this class.

Drug Class

Drug Class

  • Anticholinergic
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Anticholinergic

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Cholinergic Antagonists

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Ipratropium in the FDA’s index.

From our Patient Information GuideIpratropium is an anticholinergic medicine, meaning it blocks the action of acetylcholine — a chemical your nervous system uses to signal muscles and glands. Read How Ipratropium Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Ipratropium in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other nasal preparations
  • Anticholinergics

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

How often and how you take ipratropium depends entirely on the specific product. The inhaled aerosol forms (Atrovent HFA and Ipratropium Bromide Inhalation aerosol) are taken multiple times a day by inhaling through the mouth; the nebulizer solution is also used multiple times daily, with doses spaced through the day.

The nasal spray is sprayed into each nostril several times a day, for a short course only. None of these products are taken with food — they go directly into the lungs or nose.

  • Do not exceed the maximum daily dose listed on your product label or prescribed by your doctor.
  • The inhaled forms are for maintenance use only — not for sudden breathing emergencies.
  • The nasal spray is short-term: no more than 4 days for a cold, or 3 weeks for seasonal allergies.
  • If you miss a dose, take it as soon as you remember, but do not double up — just follow your regular schedule and ask your pharmacist if unsure.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Ipratropium Inhalation Solution (Nebulizer)

Airway tightening (bronchospasm) from COPD, including chronic bronchitis and emphysema
For adults
Usual dose 500 mcg (1 Unit-Dose Vial) three to four times a day
  • 500 mcg (1 Unit-Dose Vial) administered three to four times a day by oral nebulization, with doses 6 to 8 hours apart

Good to know

Can be mixed in the nebulizer with albuterol or metaproterenol if used within one hour

See the Full Dosing Instructions on DailyMed →

Atrovent

Airway tightening (bronchospasm) from COPD, including chronic bronchitis and emphysema
For adults · Starting dose
Starting dose Two inhalations four times a day Highest dose 12 inhalations in 24 hours
  • Patients may take additional inhalations as required

See the Full Dosing Instructions on DailyMed →

Ipratropium Bromide 42 Mcg Nasal Spray

Runny nose from the common cold or seasonal allergies
Adults and children 12 years and older (common cold) Usual dose Two sprays (84 mcg) per nostril three or four times daily
  • Two sprays (84 mcg) per nostril three or four times daily (total dose 504 to 672 mcg/day)

Good to know

Optimum dosage varies with response of the individual patient; safety and effectiveness beyond four days not established

Adults and children 5 years and older (seasonal allergies) Usual dose Two sprays (84 mcg) per nostril four times daily
  • Two sprays (84 mcg) per nostril four times daily (total dose 672 mcg/day)

Good to know

Safety and effectiveness beyond three weeks not established

Children 5 to 11 years old (common cold) Usual dose Two sprays (84 mcg) per nostril three times daily
  • Two sprays (84 mcg) per nostril three times daily (total dose of 504 mcg/day)

Good to know

Safety and effectiveness beyond four days not established

See the Full Dosing Instructions on DailyMed →

Ipratropium Bromide 21 Mcg Nasal Spray

Runny nose from year-round allergic or nonallergic rhinitis
For adults and children 6 years and older
Usual dose Two sprays (42 mcg) per nostril two or three times daily
  • Two sprays (42 mcg) per nostril two or three times daily (total dose 168 to 252 mcg/day)

Good to know

Optimum dosage varies with the response of the individual patient

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects reported across ipratropium products include:

Common side effects

  • Dry mouth
  • Headache
  • Bronchitis or worsening COPD symptoms
  • Shortness of breath (dyspnea)
  • Nausea
  • Dizziness
  • Bitter taste in the mouth
  • Sinus irritation or congestion
  • Bronchitis or COPD flares
  • Upset stomach (dyspepsia)

When to get medical help

  • Call your doctor right away if you have sudden worsening of breathing or wheezing after using the inhaler — this could be paradoxical bronchospasm, a rare but serious reaction
  • Seek emergency help if you have signs of a severe allergic reaction: hives, swelling of the face, lips, tongue or throat, or trouble swallowing
  • Contact your doctor if you notice eye pain, blurred vision, halos around lights, or redness in the eyes — these may be signs of increased pressure in the eye (narrow-angle glaucoma)
  • Tell your doctor if you have trouble urinating or feel like your bladder doesn't empty fully
  • Seek care if you experience rapid or irregular heartbeat

Warnings and Precautions

  • Not for acute attacks: The inhaled forms are maintenance medicines — they are not rescue inhalers for sudden breathing emergencies. Always have a fast-acting rescue medicine available if your doctor has prescribed one.
  • Paradoxical bronchospasm: Rarely, ipratropium can cause airways to tighten instead of opening — a potentially life-threatening reaction. Stop the medicine immediately and seek care if this happens.
  • Eye pressure risk: Ipratropium can raise pressure inside the eye and worsen narrow-angle glaucoma. Do not get the spray or aerosol in your eyes. Seek care immediately if you notice eye pain, blurred vision, or halos around lights.
  • Urinary retention: Men with an enlarged prostate and anyone with a bladder obstruction should use ipratropium cautiously — it can make urination difficult. Tell your doctor if this becomes a problem.
  • Severe allergic reactions: Anaphylaxis (a life-threatening allergic response) has been reported. Stop the medicine and get emergency help if you develop swelling of the face, lips, tongue, or throat, or have trouble breathing.

Interactions

Ipratropium has a key interaction to know about:

  • Other anticholinergic medicines: Taking ipratropium together with other anticholinergic drugs can add up their effects — increasing the risk of dry mouth, difficulty urinating, and eye pressure problems. Avoid combining them unless your doctor specifically approves it.
  • Nebulizer combinations (inhalation solution only): Ipratropium Bromide inhalation solution can be mixed with albuterol or metaproterenol in the nebulizer if used within one hour. Mixing with other drugs in the nebulizer has not been established as safe and should be avoided.

Interactions Listed in the FDA-Approved Label

From the Ipratropium prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Sympathomimetic bronchodilators, methylxanthines, oral and inhaled steroids
    What happensUsed together with ipratropium HFA in COPD; apart from albuterol, no formal studies fully evaluate safety and effectiveness of these combinations.
  • Anticholinergic medications
    What happensPotential for an additive interaction, which may increase anticholinergic adverse effects.
    What to doAvoid coadministration of ipratropium bromide HFA inhalation aerosol with other anticholinergic-containing drugs.
Read the label’s full interactions text

Drug Interactions: No controlled clinical trials were conducted to investigate potential drug-drug interactions. There is potential for an additive interaction with other concomitantly administered medications with anticholinergic properties, including Ipratropium Bromide Nasal Solution 0.06% (Nasal Spray) for oral inhalation.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Allergy to ipratropium or atropine: Do not use ipratropium if you are allergic to it, atropine, or any of its derivatives — this is a contraindication.
  • Narrow-angle glaucoma: Use with caution; ipratropium can raise eye pressure and worsen this condition.
  • Enlarged prostate or bladder obstruction: Use with caution; ipratropium can cause or worsen difficulty urinating.
  • Pregnancy: Inhaled ipratropium is negligibly absorbed into the bloodstream, so fetal exposure is expected to be very low. Published studies have not identified a drug-related risk of major birth defects. Still, discuss with your doctor.
  • Breastfeeding: Ipratropium levels in breast milk are expected to be low given how little is absorbed after inhalation. Discuss the benefits and risks with your doctor.
  • Children: The inhaled aerosol forms have not been established as safe and effective in children. The nasal spray is approved for children aged 5 and older.
  • Older adults (65+): Studies show similar effectiveness and safety in older adults compared to younger patients — no dose adjustment is specifically noted, but discuss your full health picture with your prescriber.
  • Liver or kidney disease: The pharmacokinetics of ipratropium have not been studied in people with liver or kidney problems; let your doctor know if you have these conditions.

Overdose

An overdose from the nasal spray is unlikely because ipratropium is poorly absorbed through the nasal lining and the gut. In studies, even large oral doses did not significantly change heart rate or blood pressure. If someone accidentally swallows a large amount or uses far more than prescribed, contact Poison Control or seek medical care right away as a precaution.

Half-Life and How Your Body Processes It

Ipratropium is poorly absorbed — less than 20% enters the bloodstream after nasal use, and only 2–3% is absorbed after swallowing, which is why systemic side effects are uncommon. Once in the body, it is minimally bound to proteins in the blood and does not cross into the brain. It is partially broken down by the body into inactive products, and about half of an intravenous dose is excreted unchanged in the urine within 24 hours. The half-life (the time for half the drug to clear the body) is approximately 1.6 hours after intravenous dosing.

Storage

Store tightly closed at 20° to 25°C (68° to 77°F) . Avoid freezing. Keep out of reach of children.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ipratropium: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Ipratropium — the kind of thing our pharmacy team would talk through with you at the counter.

My doctor gave me an ipratropium inhaler — can I use it when I have a sudden asthma attack?

No, the ipratropium inhaler (like Atrovent HFA) is a maintenance medicine — it's meant to be used regularly every day to keep your airways open, not as a rescue inhaler during a sudden attack. If you're having a sudden flare-up, you need a fast-acting rescue inhaler like albuterol. Make sure you have one available, and let your doctor know if you don't.

The nasal spray helps my runny nose, but can I keep using it past a week?

It depends on why you're using it. For a common cold, safety and effectiveness have only been established for up to 4 days. For seasonal allergies (hay fever), it's been studied for up to 3 weeks. Using it longer than that isn't recommended unless your doctor specifically tells you to. If your symptoms are lasting longer, check back in with your prescriber.

I got some of the inhaler spray in my eye by accident — is that a big deal?

It can be. Getting ipratropium in your eye can cause eye pain, blurred vision, redness, and in people with a certain type of glaucoma (narrow-angle glaucoma), it can raise the pressure inside the eye. If you accidentally spray it in your eye, rinse well right away. If you notice pain, vision changes, or halos around lights afterward, call your doctor promptly. Always try to aim the inhaler or nasal spray away from your eyes.

I take another medication for my bladder — is that okay to combine with ipratropium?

It depends on what your bladder medication is. If it's also an anticholinergic drug, combining it with ipratropium can increase side effects like difficulty urinating, dry mouth, and eye pressure problems. Please share a full list of your medications with your pharmacist or doctor before starting ipratropium so they can check for any overlap.

Will the ipratropium nasal spray help with my stuffy nose and sneezing too?

Unfortunately, no. The nasal spray is specifically approved to reduce a runny nose — it works by cutting down mucus production. It does not relieve nasal congestion (stuffiness) or sneezing, whether those are from a cold or from seasonal allergies. You may need a separate medicine for those symptoms, so talk to your pharmacist or doctor about what would work best for your full set of symptoms.

I'm pregnant — is it safe for me to use the ipratropium inhaler?

Inhaled ipratropium is very poorly absorbed into the bloodstream, so very little of it reaches the baby. Published studies over many years have not found a drug-related risk of major birth defects. That said, you should always let your doctor know you're pregnant so they can weigh the benefits and risks for your specific situation and make sure you're on the best treatment plan.

Is ipratropium available over the counter?

No. Ipratropium is a prescription medicine: every ipratropium product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was ipratropium first available?

The earliest FDA record we hold for ipratropium is from 1986: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when ipratropium was first used.

Who makes ipratropium?

24 companies currently list ipratropium products in the FDA's NDC Directory, including A-S Medication Solutions, Advagen Pharma Ltd, Amneal Pharmaceuticals NY LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of ipratropium?

Ipratropium is the generic name. Its brand names are Atrovent and Atrovent HFA. Generic versions are listed under the name ipratropium.

What is the generic name of Atrovent?

The generic name of Atrovent is ipratropium. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is ipratropium?

Ipratropium belongs to the drug class Anticholinergic, its established pharmacologic class on the FDA label. The FDA also groups it by how it works: Cholinergic Antagonist.

Is there a generic version of ipratropium?

Yes. FDA-approved generic versions of ipratropium are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does ipratropium come in?

Ipratropium is listed in the FDA's National Drug Code Directory in these forms and strengths. Nasal spray (in the nose): 21 mcg and 42 mcg. Inhalation solution (nebulizer) (inhaled): 0.5 mg/2.5 mL. Inhaler (inhaled): 17 mcg. A listing does not mean every pharmacy stocks every strength.

How much does ipratropium cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.38 to $0.78 per mL of the generic nasal spray across 2 strengths, $0.10 to $0.11 per mL of the 0.5 mg/2.5 mL generic inhalation solution (nebulizer), $21.67 per gram of the 17 mcg generic inhaler and $22.76 per gram of the 17 mcg inhaler of brand-name Atrovent as of November 11, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a ipratropium shortage?

No. Ipratropium is not on the FDA's drug shortage list as of Nov 18, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the ipratropium prescribing information (package insert)?

The full FDA-approved prescribing information for ipratropium, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Lupin Pharmaceuticals, Inc.'s, revised Jan 8, 2026, and links to it on DailyMed.

Is ipratropium gluten free?

No ipratropium label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 34 ipratropium products from 23 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's ipratropium by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See ipratropium inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Ipratropium

Skip the scrolling. Ask in your own words and get an answer from Ipratropium’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Ipratropium’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Ipratropium on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Ipratropium Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Ipratropium Forms and Strengths (How It Comes)

Ipratropium comes in 3 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Ipratropium inactive ingredients by manufacturer.

Nasal spray

In the nose
How this form is used
What it may be used for
  • Ipratropium Bromide nasal spray 0.06% is used to relieve a runny nose (rhinorrhea) caused by the common cold in adults and children aged 5 and older
  • Ipratropium Bromide nasal spray 0.06% is used to relieve a runny nose (rhinorrhea) caused by seasonal allergic rhinitis in adults and children aged 5 and older
  • Ipratropium Bromide nasal spray does not relieve nasal congestion or sneezing
Important instructions
  • Ipratropium Bromide nasal spray requires initial priming with 7 sprays before first use; reprime with 2 sprays if unused for more than 24 hours, or 7 sprays if unused for more than 7 days
  • Avoid spraying Ipratropium Bromide nasal spray into your eyes
  • For colds, use Ipratropium Bromide nasal spray for no more than 4 days; for seasonal allergic rhinitis, use for no more than 3 weeks
  • Follow your prescriber's or label instructions for the number of sprays per nostril and how many times per day
Available strengths 2 strengths
19 FDA-listed product records ⓘ

Inhalation solution (nebulizer)

Inhaled
How this form is used
What it may be used for
  • Ipratropium Bromide inhalation solution is used as a maintenance bronchodilator for bronchospasm associated with COPD, including chronic bronchitis and emphysema
  • Ipratropium Bromide inhalation solution can be used alone or alongside other bronchodilators, especially beta-adrenergic medicines
Important instructions
  • Ipratropium Bromide inhalation solution is taken by nebulizer, inhaled through the mouth, typically three to four times a day with doses spaced 6 to 8 hours apart
  • Ipratropium Bromide inhalation solution may be mixed in the nebulizer with albuterol or metaproterenol only if used within one hour of mixing
  • Do not mix Ipratropium Bromide inhalation solution with other drugs in the nebulizer, as safety of other combinations has not been established
  • Follow your prescriber's instructions for dosing; do not change the frequency without guidance
Available strengths 1 strength
14 FDA-listed product records ⓘ

Inhaler

Inhaled
Brands Atrovent (the first brand, 1986) Atrovent HFA (2004)
How this form is used
What it may be used for
  • Atrovent HFA is used as a maintenance bronchodilator for bronchospasm associated with COPD, including chronic bronchitis and emphysema
  • Ipratropium Bromide Inhalation aerosol is used as a maintenance bronchodilator for bronchospasm associated with COPD, including chronic bronchitis and emphysema
Important instructions
  • Atrovent HFA and Ipratropium Bromide Inhalation aerosol are for oral inhalation only — inhaled through the mouth, not the nose
  • Atrovent HFA and Ipratropium Bromide Inhalation aerosol are solution aerosols that do not require shaking, but coordination between pressing the canister and inhaling is important
  • Prime Atrovent HFA or Ipratropium Bromide Inhalation aerosol before first use by releasing 2 test sprays into the air; reprime with 2 sprays if the inhaler has not been used for more than 3 days
  • Avoid spraying Atrovent HFA or Ipratropium Bromide Inhalation aerosol into your eyes; discard the inhaler after the labeled number of actuations
Available strengths 1 strength
2 FDA-listed product records ⓘ

Ipratropium on the U.S. Market: Products, Makers and Brands

How Ipratropium appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

24 companies list 35 Ipratropium product records with the FDA, mostly as nasal spray, inhalation solution (nebulizer), inhaler; the earliest marketing or approval year on record is 1986. Brand names in the directory today include Atrovent and Atrovent HFA; the rest are generics.

3
Dose forms ⓘ
24
Labelers (makers, repackagers, distributors)
2
Brand names ⓘ
35
FDA-listed product records ⓘ
1986
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (11) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

A-S Medication Solutions9%
Advagen Pharma Ltd6%
Amneal Pharmaceuticals NY LLC6%
Apotex Corp.6%
Bausch & Lomb Incorporated6%
Bryant Ranch Prepack6%
Other makers63%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Ipratropium Is Used (Medicaid Data)

How many Ipratropium prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

583,555
Medicaid prescriptions filled (Q1–Q4 2025)
$41.5M paid by Medicaid, before rebates

How commonly is Ipratropium prescribed? Of the 1,666 medications we measure, Ipratropium ranks #247 by Medicaid prescriptions — more than 85% of them.

Where Ipratropium ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Ipratropium product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 0.2 mg/mL inhalation solution is the most-dispensed Ipratropium product — about 35% of these Medicaid prescriptions.

ipratropium bromide 0.2 MG/ML Inhalation Solution Most dispensed

204,274 Medicaid prescriptions (Q1–Q4 2025) 35% of Ipratropium prescriptions shown $4M paid by Medicaid, before rebates ≈ $19 per prescription, before rebates

20 of 48 listed NDCs had Medicaid claims. RxNorm 836358

ipratropium bromide 0.042 MG/ACTUAT Metered Dose Nasal Spray

162,187 Medicaid prescriptions (Q1–Q4 2025) 28% of Ipratropium prescriptions shown $4.1M paid by Medicaid, before rebates ≈ $25 per prescription, before rebates

7 of 11 listed NDCs had Medicaid claims. RxNorm 1797844

ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray

123,336 Medicaid prescriptions (Q1–Q4 2025) 21% of Ipratropium prescriptions shown $3.2M paid by Medicaid, before rebates ≈ $26 per prescription, before rebates

7 of 9 listed NDCs had Medicaid claims. RxNorm 1797833

200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler

93,758 Medicaid prescriptions (Q1–Q4 2025) 16% of Ipratropium prescriptions shown $30.3M paid by Medicaid, before rebates ≈ $323 per prescription, before rebates

1 of 4 listed NDCs had Medicaid claims. RxNorm 836343

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 35 of the 72 listed Ipratropium NDCs had Medicaid claims.

Compare Ipratropium Products

A representative set of FDA-listed product records for Ipratropium — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 35 of 35 products — FDA National Drug Code Directory. See every product, package size and price: browse all 35 Ipratropium NDCs →

Ipratropium Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list one Ipratropium recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Class II Apr 13, 2022 · Terminated · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
  • Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile unit-dose vials), Rx only, MFG: Nephron Pharma, NDC 0487-9801-25 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1040-2022 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 12, 2026.

Ipratropium in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
3
Strengths
4
Forms in current FDA listings
3 of 3
In current FDA listings No current FDA listing
Ingredient (IN) Ipratropium RxCUI 7213
  1. Dose form (SCDF) Inhalation Solution RxCUI 2108449
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Metered Dose Inhaler RxCUI 746447
    In current FDA listings
  3. Dose form (SCDF) Metered Dose Nasal Spray RxCUI 1797832
    In current FDA listings
    Its 2 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Ipratropium Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Ipratropium: the national average from CMS’s weekly NADAC survey, as of Nov 11, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a form, the generic or the brand, and a strength to see how its price has changed since Oct 2023.

Form
Strength

For the generic 21 mcg nasal spray, pharmacies paid an average of $0.381 per mL as of Nov 11, 2026, down 28% from $0.527 a year earlier.

What pharmacies pay now
$0.381
per mL, as of Nov 11, 2026
Last 4 weeks
Up 3.6%
from $0.368 on Oct 14, 2026
Last 12 months
Down 28%
from $0.527 on Nov 12, 2025
Lowest and highest since Oct 2023
$0.349 to $0.705
per mL

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 21 mcg nasal spray: the average pharmacy price per mL, the last survey of each month
MonthPharmacy price
Nov 2026$0.381
Oct 2026$0.381
Sep 2026$0.368
Aug 2026$0.355
Jul 2026$0.349
Jun 2026$0.366
May 2026$0.386
Apr 2026$0.399
Mar 2026$0.405
Feb 2026$0.420
Jan 2026$0.434
Dec 2025$0.449
Nov 2025$0.482
Oct 2025$0.527
Sep 2025$0.571
Aug 2025$0.618
Jul 2025$0.615
Jun 2025$0.614
May 2025$0.574
Apr 2025$0.575
Mar 2025$0.573
Feb 2025$0.551
Jan 2025$0.510
Dec 2024$0.509
Nov 2024$0.447
Oct 2024$0.582
Sep 2024$0.625
Aug 2024$0.660
Jul 2024$0.534
Jun 2024$0.625
May 2024$0.518
Apr 2024$0.524
Mar 2024$0.696
Feb 2024$0.701
Jan 2024$0.705
Dec 2023$0.612
Nov 2023$0.700
Oct 2023$0.660
FormStrengthVersion What pharmacies pay
Nasal spray · Nasal 21 mcg Generic $0.381 per mL NDC details & price history
Nasal spray · Nasal 42 mcg Generic $0.777 per mL NDC details & price history
Inhalation solution (nebulizer) · Respiratory (inhalation) 0.5 mg/2.5 mL Generic $0.103–$0.114 per mL NDC details & price history
Inhaler · Respiratory (inhalation) 17 mcg Generic $21.67 per gram NDC details & price history
Inhaler · Respiratory (inhalation) 17 mcg Atrovent (brand) $22.76 per gram NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Ipratropium Brand Names

Ipratropium has 2 brand names on record: Atrovent and Atrovent HFA. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Atrovent the first brand, 1986 Atrovent HFA 2004

Who Makes Ipratropium: Manufacturers and Labelers

24 companies list Ipratropium products with the FDA. By number of product records, the largest are A-S Medication Solutions, Advagen Pharma Ltd, Amneal Pharmaceuticals NY LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

A-S Medication Solutions 3 Advagen Pharma Ltd 2 Amneal Pharmaceuticals NY LLC 2 Apotex Corp. 2 Bausch & Lomb Incorporated 2 Bryant Ranch Prepack 2 Cardinal Health 107, LLC 2 Hikma Pharmaceuticals USA Inc. 2 Lupin Pharmaceuticals, Inc. 2 Northstar Rx Llc 2 American Health Packaging 1 Armstrong Pharmaceuticals, Inc. 1 Aurobindo Pharma Limited 1 Boehringer Ingelheim Pharmaceuticals, Inc. 1 Chartwell RX, LLC 1 Mylan Pharmaceuticals Inc. 1 Nephron Pharmaceuticals Corporation 1 NuCare Pharmaceuticals, Inc. 1 Oceanside Pharmaceuticals 1 Redpharm Drug 1 Rising Pharma Holdings, Inc. 1 Ritedose Pharmaceuticals, LLC 1 Sportpharm LLC 1 Sun Pharmaceutical Industries, Inc. 1

Sources for This Ipratropium Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jan 8, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Ipratropium.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 20 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
20
Finished products in the current FDA directory
35
Companies listing them (makers, repackagers, distributors)
24
FDA labeler codes behind them ⓘ
24
Linked representative label ⓘ
Lupin Pharmaceuticals, Inc.
Linked label effective
Jan 8, 2026
Composite sections available
19
Linked SPL Set ID
ee0ac556-8a23-4d5c-a5da-881c1fc6a339
Linked SPL Document ID
9a5c6534-8f64-4e47-bd67-71433f331d0a
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Lupin Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →